Deutsche Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Deutsche Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10	Closed	-$4K	–	5476
2019 Q1	$4K	Sell	10 -153	-94%	-$63K	﹤0.01%	5043
2018 Q4	$60K	Hold	163	–	–	﹤0.01%	4412
2018 Q3	$66K	Hold	163	–	–	﹤0.01%	4632
2018 Q2	$56K	Hold	163	–	–	﹤0.01%	4748
2018 Q1	$56K	Buy	+163	New	+$56.7K	﹤0.01%	4718
2017 Q4	–	Sell	-33	Closed	-$14K	–	5108
2017 Q3	$14K	Buy	+33	New	+$15.7K	﹤0.01%	4616
2015 Q1	–	Sell	-72	Closed	-$29K	–	5791
2014 Q4	$29K	Buy	+72	New	+$28.3K	﹤0.01%	5384
2014 Q1	–	Sell	-350	Closed	-$31K	–	5751
2013 Q4	$31K	Hold	350	–	–	﹤0.01%	4561
2013 Q3	$41K	Hold	350	–	–	﹤0.01%	4740
2013 Q2	$19K	Buy	+350	New	+$81.5K	﹤0.01%	4785

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Deutsche Bank's REGN Position: Q1 2026 in Review

Deutsche Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 18% in Q1 2026, selling an estimated $106M and leaving 625,388 shares worth $483M. The position accounts for 0.16% of the portfolio, ranked #137.

Deutsche Bank first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $590M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Deutsche Bank held 625,388 shares of Regeneron Pharmaceuticals worth $483M as of Q1 2026.
Deutsche Bank sold 138,538 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $106M.
Regeneron Pharmaceuticals made up 0.16% of Deutsche Bank's portfolio in Q1 2026, its #137 holding.
Deutsche Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Regeneron Pharmaceuticals position peaked at $590M in Q4 2025.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.